JP6130846B2 - 皮膚の色素沈着の誘導並びに皮膚の色素異常及び白斑の治療のためのｎｇｆを含有する局所用製剤 - Google Patents

皮膚の色素沈着の誘導並びに皮膚の色素異常及び白斑の治療のためのｎｇｆを含有する局所用製剤 Download PDF

Info

Publication number
JP6130846B2
JP6130846B2 JP2014539469A JP2014539469A JP6130846B2 JP 6130846 B2 JP6130846 B2 JP 6130846B2 JP 2014539469 A JP2014539469 A JP 2014539469A JP 2014539469 A JP2014539469 A JP 2014539469A JP 6130846 B2 JP6130846 B2 JP 6130846B2
Authority
JP
Japan
Prior art keywords
vitiligo
ngf
skin
topical
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2014539469A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014532694A (ja
JP2014532694A5 (enExample
Inventor
リオッタ、シルヴァナ
Original Assignee
バイオメド ベンチャー エッセ．エッレ．エッレ． ソシエタ ウニペルソナーレ
バイオメド ベンチャー エッセ．エッレ．エッレ． ソシエタ ウニペルソナーレ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by バイオメド ベンチャー エッセ．エッレ．エッレ． ソシエタ ウニペルソナーレ, バイオメド ベンチャー エッセ．エッレ．エッレ． ソシエタ ウニペルソナーレ filed Critical バイオメド ベンチャー エッセ．エッレ．エッレ． ソシエタ ウニペルソナーレ
Publication of JP2014532694A publication Critical patent/JP2014532694A/ja
Publication of JP2014532694A5 publication Critical patent/JP2014532694A5/ja
Application granted granted Critical
Publication of JP6130846B2 publication Critical patent/JP6130846B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2014539469A 2011-11-02 2012-11-02 皮膚の色素沈着の誘導並びに皮膚の色素異常及び白斑の治療のためのｎｇｆを含有する局所用製剤 Active JP6130846B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000574A ITRM20110574A1 (it) 2011-11-02 2011-11-02 Preparato topico per indurre la pigmentazione cutanea e per il trattamento di discromie cutanee e vitiligine.
ITRM2011A000574 2011-11-02
PCT/IT2012/000336 WO2013065078A2 (en) 2011-11-02 2012-11-02 Topical preparation containing ngf for inducing skin pigmentation and for the treatment of cutaneous dyschromias and vitiligo

Publications (3)

Publication Number Publication Date
JP2014532694A JP2014532694A (ja) 2014-12-08
JP2014532694A5 JP2014532694A5 (enExample) 2015-12-03
JP6130846B2 true JP6130846B2 (ja) 2017-05-17

Family

ID=45315964

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014539469A Active JP6130846B2 (ja) 2011-11-02 2012-11-02 皮膚の色素沈着の誘導並びに皮膚の色素異常及び白斑の治療のためのｎｇｆを含有する局所用製剤

Country Status (8)

Country Link
US (1) US9402906B2 (enExample)
EP (1) EP2773318B1 (enExample)
JP (1) JP6130846B2 (enExample)
CA (1) CA2854271C (enExample)
ES (1) ES2748866T3 (enExample)
IL (1) IL232419A0 (enExample)
IT (1) ITRM20110574A1 (enExample)
WO (1) WO2013065078A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201800009384A1 (it) 2018-10-11 2020-04-11 Cosmo Srl Peptide for cosmetic application
CN111282149B (zh) * 2019-08-08 2024-08-16 南京市江宁医院 一种白癜风纹饰治疗仪
IT202000005542A1 (it) * 2020-03-16 2021-09-16 Themis S R L Metodo cosmetico per il trattamento della pelle e per la ricrescita dei capelli
IT202000020287A1 (it) 2020-08-20 2022-02-20 Colosseum Combinatorial Chemistry Centre For Tech Societa A Responsabilita Limitata In Forma Abbrevi Peptide per applicazioni terapeutiche in campo dermatologico
WO2023072877A1 (en) * 2021-10-25 2023-05-04 Ellennbe Gmbh Pharmaceutical composition and kit comprising an immunomodulatory substance for treating diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7196055B2 (en) * 1994-08-31 2007-03-27 Trustees Of Boston University Inhibition of apoptosis in keratinocytes by a ligand of p75 nerve growth factor receptor
US6867179B1 (en) * 1994-08-31 2005-03-15 Trustees Of Boston University Methods of inducing hair growth and coloration
US6063757A (en) * 1995-11-29 2000-05-16 Urso; Richard G. Wound treatment method with nerve growth factor
US6143723A (en) * 1996-05-20 2000-11-07 Ramaiah; Abburi Pigmentory agent

Also Published As

Publication number Publication date
ES2748866T3 (es) 2020-03-18
WO2013065078A3 (en) 2014-01-09
JP2014532694A (ja) 2014-12-08
US9402906B2 (en) 2016-08-02
CA2854271C (en) 2018-09-11
ITRM20110574A1 (it) 2013-05-03
WO2013065078A2 (en) 2013-05-10
CA2854271A1 (en) 2013-05-10
EP2773318A2 (en) 2014-09-10
US20140242007A1 (en) 2014-08-28
IL232419A0 (en) 2014-06-30
EP2773318B1 (en) 2019-08-07

Similar Documents

Publication Publication Date Title
Gorouhi et al. Role of topical peptides in preventing or treating aged skin
US5698184A (en) Compositions and methods for skin tanning and protection
JP2024075684A (ja) 皮膚症状を改善するためのポリペプチドおよび方法
JP6130846B2 (ja) 皮膚の色素沈着の誘導並びに皮膚の色素異常及び白斑の治療のためのｎｇｆを含有する局所用製剤
KR101858095B1 (ko) 커큐민을 포함하는 강황 추출물을 유효 성분으로 포함하는 피부 미백, 주름 형성 억제, 및 소양증 완화용 화장품 조성물
JP2014177464A (ja) Ｍｎｔｆペプチドの美容および皮膚科用製剤
KR20070001921A (ko) 통상적으로 이용되는 탈색제 조성물용 이데베논의 용도와그 조성물
KR20240093957A (ko) 레티놀 및 pdrn을 포함하는 국소 조성물 및 이의 용도
JP6541589B2 (ja) 化粧用組成物における機能的なチラコイドを含む光合成細胞抽出物の使用
EP3434256B1 (en) Topical herbal compositions
KR102869820B1 (ko) 엔도텔린-1 분비, 줄기세포 인자 합성 및 단백질 카르보닐화를 감소시키기 위한 스트로브잣나무 껍질 추출물
JP2023539730A (ja) 皮膚科領域における治療用途のためのペプチド
US12156936B2 (en) Topical herbal compositions
Khalid et al. Anti-Aging topical peptides and proteins
TW201924656A (zh) 用於調節黑色素生成的方法及組成物
CN120475982A (zh) 用于皮肤再着色的组合物
ITRM20120339A1 (it) Uso di mia (attività inibitoria melanoma) per il trattamento della iper-pigmentazione cutanea e per lo sbiancamento cosmetico della pelle

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151009

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20151009

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160701

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20160916

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170104

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20170105

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20170113

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20170321

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20170414

R150 Certificate of patent or registration of utility model

Ref document number: 6130846

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250